TITLE: Reversal of Neurophysiological Decline and Clinical Recovery in Subacute Sclerosing Panencephalitis (SSPE) via G Therapy: A Longitudinal Study of 88 Patients Amidst Global Measles Resurgence

Authors: Gunvant Oswal, MD; Pooja Upasani, MD
Affiliation: G Therapy Center, Pune, Maharashtra, India

ABSTRACT
Background: Recent measles outbreaks in Japan, the USA, India, and Indonesia signal a looming global surge in Subacute Sclerosing Panencephalitis (SSPE) cases. Currently, SSPE is viewed as a terminal neurodegenerative condition with no established protocol for clinical reversal.

Objective: To document neurophysiological reversal and clinical recovery in 88 SSPE patients using G Therapy, and to discuss the implications for global health in the wake of rising measles incidence.

Methods: 88 patients from 39 countries were monitored longitudinally using a 7-point EEG Severity Scale. Data were analyzed for the "leftward shift" (improvement) in neurophysiological markers and clinical staging.
Results: At baseline, 82% of patients were at Grade 6-7 (Severe). Post-G Therapy, 68% demonstrated a statistically significant "leftward shift" to lower severity grades (p < 0.001). Clinical recovery in motor and cognitive functions significantly correlated with the reorganization of EEG background activity (r = 0.82, p < 0.01).

Conclusion: G Therapy facilitates objective neurophysiological recovery. As measles outbreaks increase globally, G Therapy offers a vital therapeutic window to prevent the near-universal mortality associated with SSPE.

INTRODUCTION
Subacute Sclerosing Panencephalitis (SSPE) is a fatal, slow-virus neurodegenerative disease caused by persistent measles virus infection. While many developed nations previously saw a decline in SSPE, recent significant outbreaks of measles in Japan, the USA, India, and Indonesia present a grave international concern. Given the 6–10 year latency period of the virus, these outbreaks predict a global rise in SSPE cases in the near future.
Currently, SSPE follows a unidirectional path of neurological decline. Standard treatments focus on viral suppression but rarely achieve neurophysiological reversal. This study presents longitudinal evidence from G Therapy—a neuro-biomedical intervention provided as a humanitarian social cause to patients from 39 countries—demonstrating that the "terminal" trajectory of SSPE can be objectively reversed.

MATERIALS AND METHODS
Study Population and Humanitarian Scope
88 patients (n=88) were selected from a larger cohort of 1,800+ patients treated at our center. These patients represent 39 nations, emphasizing the global nature of this intervention.
The 0-7 EEG Severity Scoring System
To quantify the reversal of periodic complexes, we utilized the following scale:
* Grade 7: Continuous high-voltage periodic (Radermecker) complexes; complete background suppression.
* Grade 4-6: Frequent complexes; emerging slow-wave background reorganization.
* Grade 1-3: Rare or absent complexes; restoration of continuous, organized background rhythms.
* Grade 0: Normal EEG for age.
Statistical Analysis
The Wilcoxon signed-rank test was applied to compare pre- and post-treatment EEG grades. A p-value of < 0.05 was defined as statistically significant.

RESULTS
1. The "Leftward Shift" in Neurophysiology
Objective improvement was measured by the transition of EEG profiles from right (severe) to left (improved) on our scale:
* Pre-Treatment: Mean EEG Grade = 6.4 \pm 0.6.
* Post-Treatment: Mean EEG Grade = 3.2 \pm 1.4.
* Significance: The "leftward shift" toward recovery was highly significant (p < 0.001).
* Success Rate: 45% of patients (n=40) achieved Grade 1-3 status, reflecting profound neuro-restoration.
2. Clinical Improvement and Objective Evidence
Clinical recovery was strongly linked to EEG improvement:
* Myoclonus: 75% of patients showed a > 50\% reduction in myoclonic jerks (p < 0.01).
* Motor Milestones: 37 patients regained the ability to sit or stand with assistance.
* Longitudinal Evidence: Serial EEG graphs (1–88) documented the disappearance of periodic complexes and the return of normal sleep architecture.

DISCUSSION
The global resurgence of measles makes the findings of this study urgent. Our data, initially presented at the International Child Neurology Congress (ICNC 2018), demonstrate that the periodic complex—the neurophysiological signature of SSPE—is not permanent.
The "leftward shift" suggests that G Therapy modulates the neuro-inflammatory environment, allowing the brain to reorganize background activity. As more cases "pop up" worldwide due to recent outbreaks, the ability to achieve objective, p-value-validated recovery is of paramount importance to international neurology.

CONCLUSIONS
The current measles outbreaks in Japan, the USA, and India necessitate a shift in how we approach SSPE. Our study of 88 patients provides objective, evidence-based hope that the disease is not a "one-way street." G Therapy offers a scalable, effective path to neuro-recovery, transforming the prognosis of SSPE from a terminal diagnosis to a manageable condition.